Technology Solutions

Commonwealth Informatics, FDA sign consultation agreement

Thursday, December 15, 2016

Commonwealth Informatics, a provider of clinical and safety analytics products and services, signed a new contract to support the use of advanced drug safety review tools at the FDA Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). The focus of the agreement is for Commonwealth to support the expansion of the use of the analytic suite of tools to help FDA manage their drug and product safety proactively and strategically in drug approval and post market surveillance.

[Read More]

ERT acquires Exco InTouch

Monday, December 12, 2016

ERT, a provider of high-quality patient data collection solutions for use in clinical drug development, has announced the acquisition of Exco InTouch, a provider of patient engagement, data capture and digital health solutions. The combined organization will provide the biopharmaceutical industry with the most advanced and comprehensive choice for electronic clinical outcome assessments (eCOA), patient engagement and digital health.

[Read More]

NIH competition seeks wearable device to detect alcohol levels in real-time

Thursday, December 8, 2016

The National Institute on Alcohol Abuse and Alcoholism, part of the NIH, is once again challenging the biotech community to design a wearable device capable of measuring blood alcohol in near real-time. The ideal device would be capable of measuring alcohol concentration in the blood or interstitial fluid that surrounds the body’s cells, which differs from existing technology that detects alcohol released through the skin in sweat or vapor. The creators of the winning prototype will be awarded $200,000 and second place will receive $100,000 through Challenge.gov, which lists federal incentive prizes and competitions.

[Read More]

Evotec, Merck to collaborate on target discovery technologies

Thursday, December 1, 2016

Evotec has announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck’s portfolio of genome editing technologies with Evotec’s versatile screening platforms and disease expertise. Evotec will leverage Merck’s comprehensive collection of genetic reagents such as viral CRISPR and shRNA libraries to enable new target discovery programs using its capabilities for phenotypic screening in primary and induced pluripotent stem (iPS) cells, as well as its in vivo disease models. Bringing together the complementary offerings, the two companies aim to provide fast and validated workflows to clients seeking to explore a new target space within complex disease models.

[Read More]

Wiley launches new Spectra Lab applications for analytical data

Thursday, December 1, 2016

Wiley has launched Wiley Spectra Lab Desktop edition and Wiley Spectra Lab Server edition, providing flexible options, enhanced features and essential tools for any organization managing analytical data. In addition to providing access to a collection of 2.3 million curated reference spectra, the Desktop edition allows scientists to build their own knowledge bases. The Server edition takes this one step further, providing everything the desktop has to offer combined with centralized storage and controlled access for the whole organization.

[Read More]